RXRX
Recursion Pharmaceuticals Inc
3.90$
+5.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +210.0% | +363.4% | +195.9% | -2.0% | +0.0% | +0.0% | +0.0% | +112.0% | +44.4% | +70.6% | +4.8% | -11.3% | -9.2% | -8.3% | +5.2% | +27.0% | +6.8% | +81.1% | -82.7% | +226.9% | +29.6% | -72.9% | +586.7% | -81.8% | +18.5% | – | |
| – | +3.1% | +24.8% | +25.2% | +16.5% | +22.9% | +12.2% | -92.3% | +202.8% | +82.4% | +8.3% | -29.7% | +14.8% | -24.6% | +15.9% | -9.2% | +13.0% | -17.6% | +31.3% | +5.9% | +70.6% | -7.6% | +46.8% | -9.2% | -53.5% | -8.0% | – | |
| – | – | – | +195.9% | -2.0% | +0.0% | +0.0% | +0.0% | -200.0% | – | – | – | -111.1% | – | -147.4% | – | +212.9% | +123.9% | +169.0% | -159.2% | – | – | – | – | -169.5% | – | – | |
| – | +3.1% | +24.8% | +25.2% | +16.5% | +22.9% | +12.2% | +45.3% | -32.8% | +18.5% | +6.2% | +7.7% | +6.1% | +18.0% | +27.1% | -0.7% | -2.8% | +9.4% | +0.9% | +31.8% | +31.8% | -0.8% | -5.9% | -31.2% | +5.5% | +2.0% | – | |
| – | -7.2% | +35.0% | +8.8% | +18.0% | +55.0% | +13.3% | +22.4% | +9.8% | +0.6% | -8.1% | +1.8% | +15.3% | +23.7% | +3.2% | +4.3% | +3.1% | +1.4% | +18.6% | +104.4% | -29.2% | -14.6% | -10.8% | -19.1% | +2.8% | +20.1% | – | |
| – | -0.7% | +28.1% | +20.6% | +17.2% | +31.7% | +12.6% | +37.9% | -20.7% | +11.5% | +1.0% | +6.0% | +9.0% | +19.8% | +18.5% | +0.9% | -1.0% | +7.2% | +6.2% | +56.2% | +5.0% | -4.9% | -15.6% | -20.8% | +4.7% | +7.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +41.5% | -5.9% | -42.4% | +7.8% | +904.4% | -91.2% | -99.1% | +600.0% | +0.0% | -7.1% | +0.0% | +46.2% | +36.8% | -3.8% | +4.0% | -23.1% | +1,870.0% | +40.4% | +9.4% | -16.0% | -5.5% | +73.5% | -98.7% | +3,081.8% | -11.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +796.3% | +92.7% | -134.6% | – | +960.9% | -58.5% | -98.1% | -110.5% | – | – | – | – | – | – | -352.9% | – | – | – | -95.8% | -2,357.1% | – | – | +566.7% | -23,120.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.